-
公开(公告)号:US20230010772A1
公开(公告)日:2023-01-12
申请号:US17782632
申请日:2020-12-04
Applicant: UNIVERSITY HEALTH NETWORK
Inventor: Mark R. Bray , Jacqueline M. Mason , Graham Fletcher
IPC: A61K31/5377 , A61K31/635 , A61K31/706 , A61P35/00 , A61K9/00
Abstract: The invention is related to a method of treating a subject with acute myeloid leukemia, acute lymphoblastic leukemia, chronic myeloid leukemia, non-Hodgkin’s lymphoma, Burkitt lymphoma, or diffuse large B-cell lymphoma, or myelodysplastic syndrome by administration of Compound (I): (I), or a pharmaceutically acceptable salt thereof.
-
公开(公告)号:US20220411747A1
公开(公告)日:2022-12-29
申请号:US17772385
申请日:2020-10-30
Applicant: UNIVERSITY HEALTH NETWORK
Inventor: Ming-Sound TSAO , Nikolina RADULOVICH
IPC: C12N5/00
Abstract: There is described herein a cell culture medium comprising: a basal medium; an antibiotic; B27; Noggin; Y-27632; Human FGF10 or FGF7; preferably wherein there is an absence of a Wnt agonist. Methods and uses of the medium is also described.
-
公开(公告)号:US11491180B2
公开(公告)日:2022-11-08
申请号:US17358736
申请日:2021-06-25
Applicant: University Health Network , Notogen, Inc.
Inventor: William Mark Erwin , Bjorn C. J. Eek
IPC: A61K38/18 , C07K14/495 , C07K14/475 , A61K31/7008 , A61K31/737 , A61K9/00 , A61P19/02 , A61K47/38 , A61K9/08 , C07H5/06 , A61K47/26 , C08L5/08 , A61K47/20 , A61K47/36 , C07H3/02 , A61K31/726 , C08L1/28
Abstract: There is disclosed herein compositions, methods, uses and systems for reducing pain in a patient that emanates from a body area, preferably spine or joint. Methods of treatment or prevention are described for a disease or condition selected from degenerative disc disease, disc injury, pain, arthritis, or suspected arthritis.
-
154.
公开(公告)号:US11471480B2
公开(公告)日:2022-10-18
申请号:US17358731
申请日:2021-06-25
Applicant: University Health Network , Notogen, Inc.
Inventor: William Mark Erwin , Bjorn C. J. Eek
IPC: A61K38/18 , C07K14/475 , C07K14/495 , A61K31/737 , A61K31/726 , A61K31/7008 , C07H5/06 , A61K9/00 , A61K47/38 , A61K9/08 , A61K47/26 , C08L5/08 , A61K47/20 , A61K47/36 , C07H3/02 , A61P19/02 , C08L1/28
Abstract: There is disclosed herein compositions, methods, uses and systems for reducing pain in a patient that emanates from a body area, preferably spine or joint. Methods of treatment or prevention are described for a disease or condition selected from degenerative disc disease, disc injury, pain, arthritis, or suspected arthritis.
-
公开(公告)号:US20220291215A1
公开(公告)日:2022-09-15
申请号:US17631818
申请日:2020-07-29
Applicant: University Health Network
Inventor: Naoto HIRANO , Munehide NAKATSUGAWA , Yuki YAMASHITA , Kenji SUGATA , Muhammed Aashiq RAHMAN
IPC: G01N33/569 , G01N33/554
Abstract: The present disclosure is directed to methods of identifying MHC class II-specific T cell receptors (TCRs). In certain aspects, the method comprises contacting a T cell with a complex comprising an (i) MHC class II molecule having a higher affinity for CD4 than naturally occurring MHC class II molecules and (ii) a peptide, e.g., an epitope. In certain aspects, the HLA class II molecule comprises a beta chain having one or more mutations relative to a wild-type beta chain sequence.
-
公开(公告)号:US20220281942A1
公开(公告)日:2022-09-08
申请号:US17631825
申请日:2020-07-29
Applicant: University Health Network
Inventor: Naoto HIRANO , Kenji SUGATA , Kayoko SASO
IPC: C07K14/725 , A61P35/04 , C07K16/30 , C07K14/55 , C07K14/54
Abstract: The present disclosure is directed recombinant T cell receptors capable of binding a CCND1 epitope and nucleic acid molecules encoding the same. In some aspects, the nucleic acid molecules further comprise a second nucleotide sequence, wherein the second nucleotide sequence or the polypeptide encoded by the second nucleotide sequence inhibits the expression of an endogenous TCR. Other aspects of the disclosure are directed to vectors comprising the nucleic acid molecule and cells comprising the recombinant TCR, the nucleic acid molecule, or the vector. Still other aspects of the disclosure are directed to methods of using the same. In some aspects, the methods comprise treating a cancer in a subject in need thereof.
-
157.
公开(公告)号:US20220226637A1
公开(公告)日:2022-07-21
申请号:US17607600
申请日:2020-05-06
Applicant: University Health Network
Inventor: Kumaraswamy Nanthakumar
Abstract: A multi-electrode implantable device for sensing cardiac signals and various methods for using the sensed cardiac signals are described herein. The multi-electrode device comprises a tetrahedral electrode cluster at a tip at a distal end of the lead/device; four electrodes embedded in the tetrahedral configuration; and four individual wires extending from the electrodes within the lead for receiving voltages sensed by the four electrodes. The methods can be used for deriving various physiological features that can be used in various ways including: diagnosing a physiological condition, efficient sensing of physiological signals, applying more efficient pacing by a pacemaker and indirect cardiac mapping. One or more of the physiological features may be used for applying appropriate treatment methods by a pacemaker/ICD or for applying cardiac ablation or cryofreezing.
-
公开(公告)号:US11375898B2
公开(公告)日:2022-07-05
申请号:US14719493
申请日:2015-05-22
Applicant: UNIVERSITY HEALTH NETWORK
Inventor: Ralph Sebastian Dacosta , Brian C. Wilson , Kai Zhang
Abstract: A system for acquiring data regarding a wound in tissue comprises at least one light source configured to directly illuminate a target surface with a homogeneous field of excitation light. An optical sensor is configured to detect signals responsive to illumination of an illuminated portion of a wound and the area around the wound. A thermal sensor is configured to detect thermal information regarding the illuminated portion of the wound and the area around the wound. A processor receives the detected signals and the detected thermal information and outputs data regarding the illuminated portion of the wound and the area around the wound. The output data may include wound size of the illuminated portion of the wound, bacterial load of the illuminated portion of the wound, or at least one temperature associated with the illuminated portion of the wound and the area around the wound. The data output by the processor may be displayed on a display of the system.
-
公开(公告)号:US20220181020A1
公开(公告)日:2022-06-09
申请号:US17598179
申请日:2020-03-27
Applicant: University Health Network
Inventor: Shafique Keshavjee , Marijana Zubrinic , Lukasz Brzozowski , Xun Lin , Zigang Jimmy Qiu , An Wang
IPC: G16H40/67 , G16H40/20 , G16H50/20 , A61B5/11 , A61B5/00 , G06V20/52 , G06V10/25 , G06V10/28 , G06V10/44 , G06V10/70 , H04N5/232 , G06F3/01 , G06F40/58
Abstract: A system and method for providing and managing a remote patient monitoring (RPM) system. The method is implemented by a central server, an RPM client, and a networked monitoring device. The RPM client is a software program that is executed by a computing device that is connected to the server via a network. The networked monitoring device is implemented as a locator or a smart mobile cart. More specifically, the RPM system can provide a tele-monitor with the ability to remotely monitor multiple patients, control remote cameras, and address abnormal patient situations. The RPM system can enhance tele-monitor effectiveness by detecting patient motion and tracking tele-monitor alertness.
-
公开(公告)号:US20220168347A1
公开(公告)日:2022-06-02
申请号:US17436943
申请日:2020-03-03
Applicant: University Health Network
Inventor: Naoto HIRANO , Kenji MURATA , Kayoko SASO
Abstract: The present disclosure is directed recombinant T cell receptors capable of binding a gp100 epitope and nucleic acid molecules encoding the same. In some embodiments, the nucleic acid molecules further comprise a second nucleotide sequence, wherein the second nucleotide sequence or the polypeptide encoded by the second nucleotide sequence inhibits the expression of an endogenous TCR. Other aspects of the disclosure are directed to vectors comprising the nucleic acid molecule and cells comprising the recombinant TCR, the nucleic acid molecule, or the vector. Still other aspects of the disclosure are directed to methods of using the same. In some embodiments, the methods comprise treating a cancer in a subject in need thereof.
-
-
-
-
-
-
-
-
-